Who Owns Anaergia Company?

GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Anaergia

Full Company Analysis:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

Who Owns Anaergia?

Understanding who owns a company like Anaergia is key to grasping its strategic direction and operational philosophy. As a significant player in the sustainable waste-to-value sector, Anaergia's ownership structure offers insights into its commitment to the circular economy. The company's journey includes a pivotal moment with its Initial Public Offering (IPO) on June 18, 2021, marking its debut on the Toronto Stock Exchange (TSX) under the ticker symbol 'ANRG'.

Who Owns Anaergia Company?

Founded in 2007 by Dr. Andrew Benedek, Anaergia Inc. is a Canadian company dedicated to transforming organic waste into valuable resources like renewable natural gas and fertilizer, thereby combating climate change. The company's core mission involves developing and operating infrastructure that processes organic waste and wastewater, contributing to greenhouse gas emission reductions and offering solutions such as the Anaergia BCG Matrix.

As of July 2025, Anaergia Inc. boasts a market capitalization of approximately CAD 237.95 million, with around 169.97 million shares outstanding. This indicates that Anaergia is a publicly traded company, meaning its ownership is distributed among its shareholders. The evolution of Anaergia's ownership, from its early stages to its current public status, reflects its growth and its position in the renewable energy and waste management industries. Exploring Anaergia company ownership reveals a complex interplay of founding vision, early investors, and a broad base of public shareholders.

Who Founded Anaergia?

Anaergia Inc. was established in 2007, with Dr. Andrew Benedek, a seasoned professional in water treatment and environmental solutions, at its helm. Dr. Benedek, who previously founded ZENON Environmental, envisioned Anaergia as a means to combat climate change by converting organic waste into valuable resources like renewable fuel, clean water, and fertilizer. The company's foundation was solidified through the acquisition of UTS, a German enterprise recognized for its pioneering work in high-solids digestion of agricultural waste. Anaergia Inc. was officially incorporated under the Canada Business Corporations Act on September 3, 2010, and subsequently continued under the Business Corporations Act (British Columbia) on December 21, 2018, marking its formal establishment and evolution in corporate structure.

While the precise initial equity distribution among all founders is not publicly disclosed, Dr. Andrew Benedek was the primary instigator of the company and held significant leadership roles, serving as Chairman of the Board from 2021 to 2024 and as CEO from June 2014 to June 2023. The company secured early financial backing through a C$47.5 million equity funding round in October 2013. Key investors in this round included Macquarie Capital Group Limited, Tandem Expansion Fund, Export Development Canada, and Global H2O Investments. This influx of capital also brought influential figures onto Anaergia's Board of Directors, with Duncan Murdoch representing Macquarie Capital and David Bookbinder from Tandem joining the board. Eugene Siklos of Export Development Canada was granted board observer status, indicating the early strategic influence and governance involvement of these early Anaergia investors.

Icon

Founding Vision

Dr. Andrew Benedek founded Anaergia with a mission to address climate change. His vision focused on transforming organic waste into renewable fuel, clean water, and fertilizer.

Icon

Company Genesis

Anaergia's origins trace back to the acquisition of UTS, a German company. UTS was a pioneer in the digestion of agricultural waste using high-solids technology.

Icon

Corporate Establishment

Anaergia Inc. was formally incorporated in Canada in 2010. It later underwent a continuation under British Columbia's Business Corporations Act in 2018.

Icon

Key Leadership

Dr. Andrew Benedek was instrumental in the company's founding. He served as CEO from 2014 to 2023 and as Chairman of the Board from 2021 to 2024.

Icon

Early Funding

In October 2013, Anaergia raised C$47.5 million in equity funding. This capital infusion was crucial for the company's early growth and operations.

Icon

Investor Influence

Early investors like Macquarie Capital and Tandem Expansion Fund gained board representation. Export Development Canada held board observer status, reflecting their early stake.

Icon

Early Anaergia Ownership Structure

The initial ownership of Anaergia Inc. was heavily influenced by its founder, Dr. Andrew Benedek, and its early investors who provided significant financial backing. These early Anaergia investors played a role in shaping the company's strategic direction and governance. Understanding these foundational relationships is key to grasping the Anaergia company history ownership and its subsequent development, including its approach to Revenue Streams & Business Model of Anaergia.

  • Founder: Dr. Andrew Benedek
  • Key Early Investors: Macquarie Capital Group Limited, Tandem Expansion Fund, Export Development Canada, Global H2O Investments
  • Board Representation: Directors from Macquarie Capital and Tandem Expansion Fund
  • Board Observer: Export Development Canada

Complete Anaergia Strategy Bundle

  • 6 Full Frameworks, 1 Company – All Pre-Researched
  • Each Framework Fully Sourced with Real Company Data
  • Built for Strategy Courses, Case Studies & MBA Programs
  • Adapt to Your Assignment – No Starting from Scratch
  • 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
Get Related Template

How Has Anaergia’s Ownership Changed Over Time?

The ownership of Anaergia underwent a significant transformation with its Initial Public Offering (IPO) on June 18, 2021. This event saw the company list on the Toronto Stock Exchange (TSX) under the ticker symbol 'ANRG'. The IPO was successful in generating gross proceeds of C$175 million from the sale of 12,500,000 subordinate voting shares at C$14.00 per share. An additional partial exercise of the over-allotment option further increased the total gross proceeds to C$199,367,000. This transition marked Anaergia's shift from a privately held entity to a publicly traded company with a broader base of shareholders, influencing its corporate structure and financial reporting requirements.

As of July 14, 2025, Anaergia's stock was trading at approximately $0.99 per share, with a market capitalization of $169 million and 170 million shares outstanding. This reflects a notable increase from its share price of C$0.30 on April 15, 2024, although the price on April 11, 2025, was C$0.92. Insider ownership constitutes a substantial 26.21%, while institutional ownership is relatively low at 3.18%, with no institutional owners or shareholders filing 13D/G or 13F forms with the SEC. This distribution suggests that a significant portion of Anaergia's Anaergia company stock ownership is concentrated among its founders, executives, and individual investors. Key figures in the Anaergia ownership structure include founder Dr. Andrew Benedek, alongside other executives and directors. Ohad Epschtein holds the position of Executive Chairman of the Board. The company's journey as a public entity has provided access to capital for its Growth Strategy of Anaergia, while also introducing the dynamics of public market expectations and regulatory oversight.

Ownership Type Percentage Notes
Insider Ownership 26.21% Indicates significant control by company insiders.
Institutional Ownership 3.18% Relatively low institutional investment.
Public Float Approximately 70.61% Represents shares available for trading by the general public.
Icon

Key Stakeholders in Anaergia

The Anaergia company ownership is primarily influenced by its founder and key management personnel. This structure impacts strategic decision-making and the company's direction.

  • Dr. Andrew Benedek: Founder and a significant stakeholder.
  • Ohad Epschtein: Executive Chairman of the Board.
  • Other Executives and Directors: Hold substantial insider ownership.
  • Individual Investors: A considerable portion of shares are held by individual Anaergia shareholders.

From PESTLE Factors to Full Strategy Bundle

  • PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
  • Every Strategic Angle Covered – Nothing Left to Research
  • Pre-filled with Company-Specific Research
  • No Missing Sections for Your Case Study
  • One Download Covers Your Entire Company Analysis
Get Related Template

Who Sits on Anaergia’s Board?

The governance of Anaergia Inc. is overseen by its Board of Directors, comprising both executive and independent members who guide the company's strategic direction and ensure robust oversight. Key figures on the board include Ohad Epschtein, who holds the position of Executive Chairman of the Board. Dr. Andrew Benedek, the company's founder, continues to contribute as a Director, alongside Dr. Diana Mourato Benedek, whose expertise in environmental sciences is invaluable. The board is further strengthened by independent directors such as Stan Simmons, Ronen Kantor, and Peter Gross, who serves as the Lead Independent Director, providing crucial external perspectives.

A significant restructuring of Anaergia's share capital took place around August 23, 2024, with the reclassification of its subordinate voting shares into common shares. This action effectively dismantled the previous dual-class share structure, removing any outstanding multiple voting shares from the company's authorized capital. The transition to a one-share-one-vote system for its common shares is intended to foster a more unified shareholder base and align interests across all investors as the company pursues its strategic objectives. This move is expected to enhance transparency and potentially mitigate concerns regarding concentrated control, promoting a more equitable distribution of shareholder influence.

Board Member Role Key Contribution
Ohad Epschtein Executive Chairman of the Board Strategic oversight and leadership
Dr. Andrew Benedek Director Founder's vision and industry expertise
Dr. Diana Mourato Benedek Director Environmental sciences expertise
Stan Simmons Director Independent oversight
Ronen Kantor Director Independent oversight
Peter Gross Lead Independent Director Independent oversight and governance

The reclassification of shares to a one-share-one-vote system is a pivotal step for Anaergia, simplifying its ownership structure and reinforcing its commitment to equitable shareholder representation. This aligns with the company's broader vision, as articulated by Ohad Epschtein, to better align shareholder interests. This structural change is fundamental to how Mission, Vision & Core Values of Anaergia are pursued, ensuring that all Anaergia shareholders have a consistent voice in the company's future direction.

Icon

Shareholder Alignment and Governance

Anaergia's recent share reclassification aims to create a more unified ownership structure. This move is designed to ensure that all shareholders have a consistent level of influence.

  • Elimination of dual-class shares
  • Transition to one-share-one-vote
  • Enhanced shareholder equity
  • Simplified corporate governance

Anaergia Business Model + Strategy Bundle

  • Ideal for Essays, Case Studies & Slides
  • Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
  • Company-Specific Content Already Organized
  • One Bundle Replaces Days of Independent Research
  • Buy the Bundle Once. Use Across All Your Assignments
Get Related Template

What Recent Changes Have Shaped Anaergia’s Ownership Landscape?

Over the past few years, Anaergia Inc. has seen significant shifts in its ownership. A major milestone was its Initial Public Offering (IPO) in June 2021, which transitioned the company from private to public, listing on the Toronto Stock Exchange (TSX). This move successfully raised approximately C$199.37 million, including the over-allotment option, providing capital for growth. More recently, around August 23, 2024, the company completed a reclassification of its subordinate voting shares into common shares. This action effectively eliminated the dual-class share structure and removed multiple voting shares, simplifying the company's capital structure and moving towards a one-share-one-vote system. This simplification is often viewed as a strategy to enhance corporate governance and attract a wider range of institutional investors.

As of July 2025, institutional ownership stands at a modest 3.18%. However, insider ownership is considerably higher, at 26.21%. Notably, over the last three months, insider buying has outpaced insider selling, suggesting a strong level of confidence from those within the company. Anaergia reported a record backlog of $200 million in the first quarter of 2025, marking a substantial 94% increase. Analysts project a 21% revenue growth for fiscal year 2025, though profitability is not anticipated within this year. The company has been actively securing significant agreements, particularly in Italy, and is expanding its global presence, a move that could influence future Anaergia shareholders.

Ownership Type Percentage (as of July 2025)
Institutional Ownership 3.18%
Insider Ownership 26.21%

The company's recent financial performance and strategic expansions, such as its notable agreements in Italy and broader global reach, are key factors that will likely shape its future Anaergia company ownership trends. These developments, coupled with the simplified share structure, could attract increased interest from various Anaergia investors and potentially alter the Anaergia shareholders' composition in the coming periods.

Icon Recent Financial Performance

Anaergia reported a record backlog of $200 million in Q1 2025, a 94% increase year-over-year. Analysts project 21% revenue growth for fiscal year 2025.

Icon Ownership Structure Evolution

The company transitioned to a public entity via IPO in June 2021 and reclassified subordinate voting shares to common shares in August 2024, simplifying its capital structure.

Icon Insider Confidence

Insider ownership is substantial at 26.21%. Insider buying has exceeded insider selling in the past three months, indicating internal confidence in the company's direction.

Icon Global Expansion and Agreements

Anaergia is actively signing significant agreements, particularly in Italy, and is expanding its global footprint. Understanding this expansion is key to analyzing the Competitors Landscape of Anaergia.

From Five Forces to Full Company Analysis

  • Includes SWOT, PESTLE, BMC, BCG and 4P's
  • Pre-Researched with Company-Specific Data
  • Best Value for a Complete Analysis
  • Ready to Adapt for Your Case Study
  • Ready for Essays and Slidesd
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.